37% of GPs surveyed believe that medical cannabis has the potential to reduce patient dependency on other medications.
Researchers found no association between more potent cannabis and an increased risk of dependence or psychosis-like symptoms.
Only 8% products had concentrations within 10% of the advertised strength.
The trial on non-cancer related chronic pain will recruit up to 5,000 patients.
Your weekly debrief of the latest cannabis news.
Oxford Cannabinoid Technologies is expanding its research and development into oncology.
Researchers say medicinal cannabis may play a 'harm-reduction' role, helping veterans use fewer pharmaceutical medications and other substances.
Your weekly debrief of the latest cannabis news.
The change in law to permit the prescribing of cannabis for medicinal purposes has had little impact on recreational use, according to a new study. In...
Pain is the most common indication to be studied in cannabinoid clinical trials since 2010, says an upcoming report.
